Clinical and imaging outcome
| Patient No | Clinical presentation | Aneurysm localization and size (mm) | Stent diameter and length | Complications | Clinical assessment | Angiographic results at final follow-up (24 months) | mRS at final follow-up |
|---|---|---|---|---|---|---|---|
| 1 | TIA | VBJ/35 | 5.5×45 4.5×40 | None | mRS=0 | CO | 1 |
| 2 | TIA | PICA/35 | 2.5×12 | Retroperitoneal hematoma | mRS=0 | CO | 1 |
| 3 | Mass effect | ICA/8 | 4.5×25 | None | mRS=1 | PSO | 1 |
| 4 | Mass effect | ICA/8 | 4.5×500 | Minor stroke | mRS=1 | CO | 2 |
| 5 | TIA | LVA/8 | 3.5×25 3.5×18 | None | mRS=1 | CO | 1 |
| 6 | SAH | PCA/8 | 2.5×12 | None | H&H=1 | CO | 1 |
| 7 | Mass effect | BA/8 | 4.5×40 4.5×20 | Intra-stent thrombosis | mRS=0 | CO | 2 |
| 8 | TIA | VBJ/35 | 5.5×50 4.5×40 | None | mRS=1 | PSO | 1 |
| 9 | Mass effect | ICA/8 | 3.5×35 | Minor stroke | mRS=0 | CO | 2 |
| 10 | HSA | LVA/8 | 3.5×25 3.5×18 | None | H&H=2 | CO | 1 |
| 11 | TIA | ICA/8 | 3.5×35 | None | mRS=1 | CO | 1 |
| 12 | TIA | PICA/35 | 4.5×40 | None | mRS=1 | PSO | 1 |
| 13 | Mass effect | MCA/8 | 3.5×25 | Femoral hematoma | mRS=1 | CO | 1 |
| 14 | TIA | PICA/35 | 2.5×12 | None | mRS=1 | CO | 1 |
| 15 | HSA | Left PCA/8 | 2.5×18 | None | H&H=1 | CO | 1 |
| 16 | Mass effect | BA/8 | 5.5×40 | Femoral hematoma | mRS=1 | CO | 1 |
| 17 | TIA | CPA/8 | 2.5×12 | None | mRS=1 | CO | 1 |
| 18 | TIA | LVA/8 | 3.5×18 | None | mRS=1 | PSO | 1 |
| 19 | Mass effect | VBJ/35 | 5.5×45 4.5×40 4.5×20 | Minor stroke | mRS=1 | CO | 2 |
| 20 | TIA | RVA/8 | 3.5×25 3.5×25 | None | mRS=1 | PSO | 1 |
BA, basilar artery; CO, complete occlusion; H&H, Hunt and Hess Scale; ICA, internal carotid artery; LVA, left vertebral artery; MCA, middle cerebral artery; mRS, modified Rankin Scale; PCA, posterior cerebral artery; PICA, posteroinferior cerebellar artery; PSO, partial stable occlusion; RVA, right vertebral artery; SAH, subarachnoid hemorrhage; TIA, transient ischemic attack; VBJ, vertebrobasilar junction.